Article info
PDFTherapeutics/Prevention
Randomised controlled trial
Prophylactic low-dose hydrocortisone treatment increases the rate of survival without bronchopulmonary dysplasia in extremely preterm infants
- Correspondence to: Professor Anton van Kaam, Department of Neonatology, Emma Children's Hospital Academic Medical Center, Amsterdam 1105 AZ, The Netherlands; a.h.vankaam{at}amc.uva.nl
Citation
Prophylactic low-dose hydrocortisone treatment increases the rate of survival without bronchopulmonary dysplasia in extremely preterm infants
Publication history
- First published August 11, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/